PHASE 2 STUDY
Clinical trials for PHASE 2 STUDY explained in plain language.
Never miss a new study
Get alerted when new PHASE 2 STUDY trials appear
Sign up with your email to follow new studies for PHASE 2 STUDY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to wipe out lingering cancer cells in aggressive lymphoma
Disease control Not yet recruitingThis study is testing if adding a drug called glofitamab after standard initial treatment can better control a fast-growing type of blood cancer called mantle cell lymphoma (MCL). It is for adults newly diagnosed with a high-risk form of MCL who have not yet started treatment. Th…
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
New injection aims to stop Leukemia's return
Disease control Not yet recruitingThis study is testing whether giving the drug blinatumomab as an injection under the skin can help control very low levels of leukemia cells and prevent the cancer from coming back. It will involve about 40 adults with B-cell acute lymphoblastic leukemia who are in remission but …
Matched conditions: PHASE 2 STUDY
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC